Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives) (Q28367704)
scientific article
Language:
Current Data About Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)
(P31) (Q13442814)

(P50) (Q13578863)
(P1545) 6
(P1932) E De Clercq

(Q31332118)
(P1545) 1
(P1932) J Balzarini

(Q42323764)
(P1932) A Karlsson
(P1545) 7

(P304) 5470-4

(P407) (Q1860)

(P433) 12

(P478) 92

(P577) Tuesday, June 6, 1995

(P1433) (Q1146531)

(P1476) "Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)" (language: en)

(P2093) M J Pérez-Pérez
(P1545) 2

S Vélazquez
(P1545) 3

A San-Félix
(P1545) 4

M J Camarasa
(P1545) 5

(P2860) (Q28368053)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28368045)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28368028)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28324214)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28323994)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28323972)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28318330)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28318254)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28316231)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28316183)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q28316126)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Monday, March 20, 2017

(Q36651931)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Friday, September 29, 2017

(Q36674690)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Friday, September 29, 2017

(Q42278116)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Saturday, June 2, 2018

(Q42277979)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41716
(P813) Saturday, June 2, 2018

other details